EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation

Evelyn Lepka de Lima, Ana Angélica Lindoso, Giovanna Mariah Orlandi, Suely Fukasava, Catia Martinez, Julio Croda, C. Robert Horsburgh, Otavio Ranzani, Meredith B. Brooks, Jason R. Andrews

PLOS Medicine · 18.11.2026 · 23 (11) · e1005303

DOI: 10.1371/journal.pmed.1005303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 18.11.2026. Verfasst von Evelyn Lepka de Lima und 9 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Loss to follow-up (LTFU) during tuberculosis treatment is a major programmatic gap, but how much excess mortality it causes has been difficult to estimate, because individuals who disengage differ from those who do not, and they must survive long enough to be recorded as having disengaged. Quantifying this excess and identifying which populations are at greatest risk are critical to informing program design and resource allocation. Methods and findings We followed 171,048 people aged 15 years or older starting a first course of tuberculosis treatment in São Paulo State, Brazil, between 2013 and 2023, linking surveillance and mortality registries; 20,830 (12.2%) were LTFU, defined as interruption of treatment for at least 30 consecutive days. Among those LTFU, 65% had received directly observed therapy (DOT). Using a clone-censor-weight target trial emulation, we contrasted two strategies over 60 months from the first day of treatment: disengagement at any point during the first 6 months and remaining in care throughout. Analyses were adjusted for age, sex, race, education, HIV status, diabetes, alcohol use, drug use, incarceration, homelessness, hospitalization at diagnosis, clinical form of tuberculosis, DOT, and municipality. A rolling landmark analysis addressed the timing of disengagement and cause-specific mortality excess. LTFU increased standardized 5-year mortality by 2.49 percentage points (95% CI [1.94, 3.17]). In a rolling landmark analysis, tuberculosis accounted for 61% of the 5-year excess mortality. Relative effects were largest in younger, stably housed individuals, whose baseline mortality was low; the largest absolute excess fell on people living with HIV (5.16 percentage points, 95% CI [3.76, 6.60]). The excess was similar for disengagement at any point in the first 4 months of treatment and attenuated thereafter. Limitations include the absence from the registry of severity markers such as radiographic extent and bacillary load, so residual confounding cannot be excluded.

Conclusions

Despite high DOT coverage, disengagement during the first 6 months of tuberculosis treatment was common and increased 5-year mortality under the stated identification assumptions, with the excess concentrated in deaths attributed to tuberculosis. Interventions that provide support throughout treatment should be tested for their effectiveness in sustaining engagement and reducing mortality.

Zitieren

APA

Lima, E. L. D., Lindoso, A. A., Orlandi, G. M., Fukasava, S., Martinez, C., Croda, J., Horsburgh, C. R., Ranzani, O., Brooks, M. B., & Andrews, J. R. (2026). Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation. PLOS Medicine, 23(11), e1005303. https://doi.org/10.1371/journal.pmed.1005303

Vancouver

Lima ELD, Lindoso AA, Orlandi GM, Fukasava S, Martinez C, Croda J, et al. Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation. PLOS Medicine. 2026;23(11):e1005303. doi:10.1371/journal.pmed.1005303

BibTeX
@article{Lima2026,
  author = {Lima, Evelyn Lepka de and Lindoso, Ana Angélica and Orlandi, Giovanna Mariah and Fukasava, Suely and Martinez, Catia and Croda, Julio and Horsburgh, C. Robert and Ranzani, Otavio and Brooks, Meredith B. and Andrews, Jason R.},
  title = {Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation},
  journal = {PLOS Medicine},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {e1005303},
  doi = {10.1371/journal.pmed.1005303}
}
Kostenlos starten →